Shopping Cart
Remove All
Your shopping cart is currently empty
NP-BTA, an allosteric inhibitor of glutaminyl-tRNA synthetase (GlnRS), demonstrates antifungal activity against Candida albicans, with a MIC50 of 6.25 μM [1].

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | 10-14 weeks | 10-14 weeks | |
| 50 mg | Inquiry | 10-14 weeks | 10-14 weeks |
| Description | NP-BTA, an allosteric inhibitor of glutaminyl-tRNA synthetase (GlnRS), demonstrates antifungal activity against Candida albicans, with a MIC50 of 6.25 μM [1]. |
| In vitro | NP-BTA (300 μM) inhibits GlnRS by binding with His6-Gln4 (K D of 180 nM), thereby preventing the aminoacylation of tRNA Gln, with an IC 50 of 106 nM [1]. |
| In vivo | NP-BTA (0.096–0.27 g 2% NP-BTA cream, applied twice daily for 7 days) helps protect immunosuppressed CD-1 mice from infection by T. mentagrophytes conidia [1]. Animal Model: Immunosuppressed CD-1 mice infected with T. mentagrophytes [1] Dosage: 0.096–0.27 g 2% NP-BTA cream Administration: Topical application, twice daily for 7 days Result: Reduced fungal burden. |
| Molecular Weight | 231.27 |
| Formula | C11H9N3OS |
| Cas No. | 544420-99-7 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.